代谢性肥胖与泌尿系统癌症
Metabesity and urological cancers.
作者信息
Atan Ali
机构信息
Department of Urology, Gazi University School of Medicine, Ankara, Turkey.
出版信息
Turk J Urol. 2017 Dec;43(4):410-413. doi: 10.5152/tud.2017.66502. Epub 2017 Dec 1.
Abstract
Metabolic syndrome is one of today's most important health problems. Due to increased prevalence of metabolic syndrome in society, studies done on this topic have increased in number. Although metabolic syndrome was previously considered to be important only for cardiovascular health, it has been learned that with new data, human health is compromised more thoroughly by metabolic syndrome and is also a danger to malignancy. As a result, a new definition in the form of metabesity has been introduced. In this review, available information on metabesity and urological cancers is presented.
摘要
代谢综合征是当今最重要的健康问题之一。由于社会中代谢综合征的患病率上升，关于这一主题的研究数量也有所增加。尽管代谢综合征以前仅被认为对心血管健康很重要，但从新数据中了解到，代谢综合征对人类健康的危害更为全面，并且也是恶性肿瘤的一个危险因素。因此，引入了一种新的定义形式，即代谢性肥胖。在这篇综述中，呈现了关于代谢性肥胖和泌尿系统癌症的现有信息。
相似文献
1
Metabesity and urological cancers.代谢性肥胖与泌尿系统癌症
Turk J Urol. 2017 Dec;43(4):410-413. doi: 10.5152/tud.2017.66502. Epub 2017 Dec 1.
2
Metabesity: expert panel recommendation for taking up the challenge by a multidisciplinary approach.代谢性肥胖：多学科方法应对挑战的专家小组建议
J Pak Med Assoc. 2020 Aug;70(8):1418-1424. doi: 10.5455/JPMA.56654.
3
Advances in Genetics of Regeneration in Metabesity.代谢肥胖症再生遗传学研究进展。
Genes (Basel). 2019 May 20;10(5):383. doi: 10.3390/genes10050383.
4
Dissecting the Brain/Islet Axis in Metabesity.解析代谢肥胖中的脑/胰岛轴
Genes (Basel). 2019 May 8;10(5):350. doi: 10.3390/genes10050350.
5
Role of C-reactive protein in urological cancers: a useful biomarker for predicting outcomes.C 反应蛋白在泌尿系统癌症中的作用：一种预测结果的有用生物标志物。
Int J Urol. 2013 Feb;20(2):161-71. doi: 10.1111/j.1442-2042.2012.03121.x. Epub 2012 Aug 16.
6
Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes.局限性前列腺癌患者生化复发定义的差异：美国泌尿外科学会局限性前列腺癌指南更新小组报告及手术结果报告标准的建议。
J Urol. 2007 Feb;177(2):540-5. doi: 10.1016/j.juro.2006.10.097.
7
Current Trends in the Incidence and Survival Rate of Urological Cancers in Korea.韩国泌尿系统癌症发病率和生存率的当前趋势
Cancer Res Treat. 2017 Jul;49(3):607-615. doi: 10.4143/crt.2016.139. Epub 2016 Sep 23.
8
Multicenter prospective study validating the efficacy of a quantitative assessment tool for frailty in patients with urological cancers.多中心前瞻性研究验证了一种用于评估泌尿系统癌症患者虚弱程度的定量评估工具的疗效。
Med Oncol. 2019 Sep 13;36(10):88. doi: 10.1007/s12032-019-1313-x.
9
10
Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population.采用美国国家胆固醇教育计划和国际糖尿病联盟的定义，评估韩国人群中代谢综合征的患病率及心血管疾病风险。
Metabolism. 2007 Apr;56(4):552-8. doi: 10.1016/j.metabol.2006.12.003.
引用本文的文献
1
Normal Weight, Overweight and Obesity Conditions Associated to Prostate Neoplasm Stages-A Systematic Review and Meta-Analysis.与前列腺肿瘤分期相关的正常体重、超重和肥胖状况——一项系统评价与荟萃分析
Biomedicines. 2025 May 13;13(5):1182. doi: 10.3390/biomedicines13051182.
2
2,4 Dinitrophenol as Medicine.2,4-二硝基苯酚作为药物。
Cells. 2019 Mar 23;8(3):280. doi: 10.3390/cells8030280.
本文引用的文献
1
Prospective investigation of risk factors for prostate cancer in the UK Biobank cohort study.英国生物银行队列研究中前列腺癌风险因素的前瞻性调查。
Br J Cancer. 2017 Nov 7;117(10):1562-1571. doi: 10.1038/bjc.2017.312. Epub 2017 Sep 14.
2
Components of metabolic syndrome and prognosis of renal cell cancer.代谢综合征的组成部分与肾细胞癌的预后
Scand J Urol. 2017 Dec;51(6):435-441. doi: 10.1080/21681805.2017.1352616. Epub 2017 Jul 26.
3
Adiponectin: Its role in obesity-associated colon and prostate cancers.脂联素：其在肥胖相关结肠癌和前列腺癌中的作用。
Crit Rev Oncol Hematol. 2017 Aug;116:125-133. doi: 10.1016/j.critrevonc.2017.06.003. Epub 2017 Jun 9.
4
Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidences.代谢综合征、内分泌干扰物与前列腺癌的关联：生化及病理生理学证据
Oncotarget. 2017 May 2;8(18):30606-30616. doi: 10.18632/oncotarget.16725.
5
Meta-analysis of metabolic syndrome and prostate cancer.代谢综合征与前列腺癌的荟萃分析。
Prostate Cancer Prostatic Dis. 2017 Jun;20(2):146-155. doi: 10.1038/pcan.2017.1. Epub 2017 Feb 21.
6
Association between Metabolic Syndrome and Cancer.代谢综合征与癌症之间的关联。
Ann Nutr Metab. 2016;68(3):173-9. doi: 10.1159/000443743. Epub 2016 Feb 20.
7
Obesity, adipose tissue function and the role of vitamin D.肥胖、脂肪组织功能与维生素D的作用
Cent Eur J Immunol. 2014;39(2):260-4. doi: 10.5114/ceji.2014.43732. Epub 2014 Jun 27.
8
The metabolic syndrome and cancer: Is the metabolic syndrome useful for predicting cancer risk above and beyond its individual components?代谢综合征与癌症：代谢综合征在预测癌症风险方面，除其各个组成部分外是否具有额外的作用？
Diabetes Metab. 2015 Dec;41(6):463-9. doi: 10.1016/j.diabet.2015.04.006. Epub 2015 May 30.
9
Metabolic syndrome and risk of cancer: which link?代谢综合征与癌症风险：有何关联？
Metabolism. 2015 Feb;64(2):182-9. doi: 10.1016/j.metabol.2014.10.008. Epub 2014 Oct 18.
10
Metabolic syndrome and diabetes for the urologist.泌尿外科医生眼中的代谢综合征与糖尿病
Can Urol Assoc J. 2014 Jul;8(7-8 Suppl 5):S159-61. doi: 10.5489/cuaj.2314.
Zotero 插件